InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Dawn Carter Bir, Chief Commercial Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 9 open-market SEC Form 4 transactions: 0 purchases worth $0 and 9 sales worth $14.5M, reported from Mar 3, 23 to Aug 16, 23. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 16, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 398 | $168.33 | $67K |
| Aug 15, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 807 | $169.04 | $136K |
| Jul 28, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 40.0K | $164.54 | $6.6M |
| May 16, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 417 | $80.96 | $34K |
| May 15, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 894 | $85.09 | $76K |
| Mar 13, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 9.3K | $86.77 | $808K |
| Mar 7, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 36.0K | $86.67 | $3.1M |
| Mar 6, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 40.1K | $90.26 | $3.6M |
| Mar 3, 23 | RETAREATA PHARMACEUTICALS INC | SELL | 2.2K | $88.25 | $191K |